Viewing Study NCT07193394


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-01-17 @ 12:17 AM
Study NCT ID: NCT07193394
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-25
First Post: 2025-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Sponsor: Institut Curie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module